High Efficient Atsb Injection Azithromycin Tilmicosin Bromhexin for Cattle Sheep

Name: High Efficient Atsb Injection Azithromycin Tilmicosin Bromhexin for Cattle Sheep
Brand: Hebei Guangren Pharmaceutical Technology Co., Ltd.
SKU: 1952258562

Hebei, ChinaHebei Guangren Pharmaceutical Technology Co., Ltd.

US$1.80-2.50

2,000 bottle

Sample price:US$5.00/bottle.Request sample

Product profile

Customization

Available

Varieties

Infectious Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Type

The First Class

Pharmacodynamic Influential Factors

Repeated Medication

Storage Method

Light Proof

Veterinary Reg. No.

1048

Transport Package

100ml/Bottle

Specification

100ml/bottle

Trademark

GRDR

Origin

Hebei

HS Code

294190

Production Capacity

100000bottles/Weeks

Company profile

Hebei Guangren Pharmaceutical Technology Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2011-05-11Nearest Port: XINGANG QINGDAOAverage Response Time: ≤11.36hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF

AI-Powered supplier vetting

SummaryHebei Guangren Pharmaceutical Technology Co., Ltd. is identified as a private Chinese manufacturer/factory specializing in more than 300 veterinary drug and animal-health products, including injections, powders, premixes, oral liquids, tablets, disinfectants, and feed additives. It reports five production lines, exports to multiple global regions, and holds BSCI, ISO 9000, and GMP certifications. The company describes structured raw-material, production-process, and multi-level product inspections, supported by 41–50 quality-control staff. Its stated R&D investment, sophisticated equipment, and product-development system indicate innovation activity, although the reported R&D engineering experience is below five years. Production lead time is within 15 working days off season and one month during peak season. Evidence is insufficient to confirm after-sales capability, customization capability, financial credibility, or specific customer cases.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is a private company based in Shijiazhuang, Hebei, China. Its stated business focuses on manufacturing more than 300 veterinary drug and animal-health products, although one slice also describes the associated company nature as a trading company.

CertificationsThe supplier reports holding BSCI, ISO 9000, and GMP management-system certifications. These certifications provide explicit evidence of formal compliance and quality-management credentials, though the slices do not specify certificate scope, issuing bodies, or validity dates.

R&D capabilityThe company states that it invests in sophisticated equipment and new-product development, operates a scientific R&D system, and introduces dozens of new products annually. These statements explicitly support ongoing product-development activity and product-structure optimization, although the reported total R&D engineer experience is below five years.

Production capacityThe supplier reports five production lines, production of 500,000,000 veterinary-medicine boxes, more than 300 product types, 41–50 quality-control staff, and multi-level inspections. It states an off-season fulfillment time within 15 working days and a peak-season lead time of one month, providing explicit evidence of established production and quality-control capacity.